Industrial Toxins and Fulminant Hepatitis: Dr. Rakela replies
β Scribed by Rakela, Jorge
- Book ID
- 122847332
- Publisher
- Mayo Clinic
- Year
- 1985
- Tongue
- English
- Weight
- 146 KB
- Volume
- 60
- Category
- Article
- ISSN
- 0025-6196
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Hepatitis B virus DNA and hepatitis D virus RNA, the most sensitive markers of hepatitis B and hepatitis D virus replication, were sought by molecular hybridization with radioactive probes in serial serum samples from 29 consecutive patients with HBsAg-positive fulminant hepatitis. Nineteen patients
Clinical profiles, serological markers, and antibody responses to antigens of hepatitis B virus (HBV) were studied in patients with fulminant viral hepatitis. Whereas hepatitis A and B were found to be uncommon causes (6.9% and 12.2%, respectively), non-A, non-B (NANB) hepatitis was found to be the
We assessed prognostic factors in 115 patients with serologically defined fulminant hepatitis B. The diagnosis in each case WM based on the finding of IgM antibody to the hepatitis B core antigen in serum. Multivariate analysis showed that factor V level (p < 0.001), patient's age (p = 0.001), absen